세계의 외골격 시장 : 대상 부위별, 동작 모드별, 외골격 형태별, 이동성별, 주요 지역별 업계 동향과 예측

Exoskeleton Market: Overview

As per Roots Analysis, the global exoskeleton market is estimated to grow from USD 2.9 billion in the current year to USD 20.3 billion by 2035, at a CAGR of 22.4% during the forecast period, till 2035.

The market sizing and opportunity analysis has been segmented across the following parameters:

Body Part Covered:

• Upper Extremity
• Lower Extremity
• Full Body

Mode of Operation:

• Powered
• Passive
• Hybrid

Form:

• Powered
• Passive
• Hybrid

Mobility

• Fixed / Supported
• Mobile

End Users

• Patients
• Healthcare Providers

Key Geographical Regions

• North America
• Europe
• Asia-Pacific
• Rest of the World

Medical Exoskeleton Market: Growth and Trends

Over the years, significant advancements have occurred in robotic technologies, leading to enhanced usability of exoskeletons across different sectors for aiding and supporting humans. Especially in healthcare, these devices have demonstrated significant potential in aiding both patients and medical professionals. It is important to mention that even after decades of study and numerous possible applications, exoskeletons have not become the favored choice for stakeholders because of competition from other mobility systems and prosthetic devices often used in clinical and domestic environments.

Exoskeletons in healthcare mainly support rehabilitation, gait training, and mobility for those with spinal cord injuries (SCI), strokes, neurological conditions, or age-related disabilities. Further, demographic changes, especially in areas such as Asia-Pacific, heighten the demand for mobility improvements and elder care, with exoskeletons boosting rehabilitation results by 23% in motor function recovery at certain US clinics.

To ensure widespread approval, developers are concentrating on meeting real needs with their exoskeleton designs. They are actively seeking innovations to address issues related to cost-efficiency and user discomfort, striving to turn exoskeletons into more organic and integrated second skin solutions instead of cumbersome robotic suits. Additionally, developers are incorporating artificial intelligence and machine learning to allow devices to recognize the user's intentions and enhance human-robot interactions via suitable control algorithms. Moreover, innovations such as virtual reality (VR), augmented reality (AR), tailored games, or a mix of these methods are being implemented to improve robotic therapy by boosting patient involvement and ensuring they stay dedicated to completing their assigned exercises. Due to technological progress and continual developments in this area, exoskeleton devices are expected to have significant potential in the years to come.

Exoskeleton Market: Key Insights

The report delves into the current state of the exoskeleton market and identifies potential growth opportunities within the industry. Some key findings from the report include:

• Presently, over 200 exoskeletons are available / under development to provide support to patients with mobility impairments or reduce the risk of musculoskeletal injuries among caregivers dealing with disabled patients.

• Over 100 medical exoskeletons, both rigid and soft, cover different parts of the body and are typically operated using batteries that power the sensors and actuators; over 60% of them capture the motion metrics of patients.
• Developers of medical exoskeletons have established a global presence; more than 40% of these players are based in Europe, primarily in countries, such as Germany and Switzerland.
• With the growing demand for medical exoskeletons amongst patients, several types of strategic deals have been inked in this domain; majority (26%) of partnerships signed were distribution agreements.
• In order to increase adoption rates and maximize return on investment (ROI) for the users, developers of medical exoskeletons are striving to reduce costs while incorporating advanced features into their portfolio of devices.
• Nearly 3,800 patents related to exoskeletons have been filed / granted since 2016, indicating the substantial efforts made by researchers engaged in this domain.
• The pioneer-migrator-settler map in blue ocean strategy analysis suggests that several medical exoskeleton developers focused on enhancing their product features are likely to emerge as pioneers in the coming years.

• In 2035, nearly 80% of the exoskeleton market is likely to be driven by the sales of rigid exoskeletons primarily supporting the lower body, in patients with muscle weaknesses or complete / partial paraplegia.

Medical Exoskeleton Market: Key Segments

Currently, Lower Body Exoskeleton Segment Occupies the Largest Share of the Medical Exoskeleton Market

In terms of the body part covered, the market is segmented into upper body exoskeletons, lower body exoskeletons and full body exoskeletons. At present, the lower body exoskeleton segment holds the maximum share of the medical exoskeleton market. This is due to the steep price of lower body exoskeletons and an increase in the number of companies providing lower body medical exoskeletons. It is worth highlighting that the exoskeleton market for full body medical exoskeletons is anticipated to grow at a higher CAGR.

Passive Exoskeletons Segment is the Fastest Growing Segment of the Exoskeleton Market During the Forecast Period

In terms of the mode of operation, the market is segmented into powered exoskeletons, passive exoskeletons and hybrid exoskeletons. The passive exoskeletons segment is expected to expand at a comparatively faster growth rate throughout the forecast period. This is due to the devices offering necessary ergonomic assistance without requiring actuators or batteries, resulting in decreased initial costs and lower maintenance expenses for the users. However, currently, the powered medical exoskeleton segment holds the maximum share of the medical exoskeleton market. This trend is unlikely to change in the near future.

Currently, Rigid Exoskeletons Segment Occupies the Largest Share of the Medical Exoskeleton Market

In terms of their form, the market is segmented into rigid exoskeletons and soft exoskeletons. Due to their extensive use, rigid exoskeletons dominate the medical exoskeleton market. It is worth noting that soft exoskeletons segment is likely to grow at a relatively higher CAGR.

Currently, Mobile Medical Exoskeletons Occupy the Largest Share of the Medical Exoskeleton Market

In terms of mobility, the market is segmented into stationary exoskeletons and mobile exoskeletons. It is worth highlighting that, at present, mobile / overground walking medical exoskeleton holds a larger share of the medical exoskeleton market. This is owing to the fact that exoskeletons enable patients to engage in activities such as standing, climbing stairs, or walking, which are vital for restoring functional independence. Moreover, mobile exoskeletons can be utilized in different settings, such as outpatient clinics, residential areas, and communal spaces, allowing patients to pursue their rehabilitation beyond conventional healthcare environments.

Currently, Patient-Focused Exoskeletons are Expected to Capture the Largest Share of the Medical Exoskeleton Market

In terms of the end-user, the market is segmented into patients and healthcare professionals. It is important to note that a significant share of the existing medical exoskeleton market is dominated by patient-oriented exoskeletons.

North America Accounts for the Largest Share of the Market

Based on key geographical regions, the market is segmented into North America, Europe, Asia-Pacific and Rest of the world. It is worth highlighting that, over the years, the market in the rest of the world is expected to grow at a higher CAGR.

Example Players in the Exoskeleton Market

• Bionic Yantra
• CYBERDYNE
• Ekso Bionics
• ExoAtlet
• Fourier Intelligence
• Gloreha
• Guangzhou Yikang Medical Equipment
• Hexar Humancare
• Hocoma
• MediTouch
• Milebot Robotics
• Myomo
• Neofect
• NextStep Robotics
• Panasonic
• ReWalk Robotics
• Rex Bionics
• Roam Robotics
• Trexo Robotics
• Tyromotion
• U&O Technologies

Primary Research Overview

The opinions and insights presented in this study were influenced by discussions conducted with multiple stakeholders. The research report features detailed transcripts of interviews held with the following industry stakeholders:

• Co-Founder and Chief Executive Officer, Company A
• Director of Business Planning and Development, Company B
• Vice President of Sales and Marketing, Company C
• Marketing and Design Manager, Company D
• Founder and Director, Company E

Medical Exoskeleton Market: Research Coverage

• Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the exoskeleton market, focusing on key market segments, including [A] body part covered, [B] mode of operation, [C] mobility, [D] end users and [F] key geographical regions.
• Market Landscape: A comprehensive evaluation of medical exoskeletons, considering various parameters, such as [A] status of development, [B] body part covered, [C] mode of operation, [D] form of exoskeleton, [E] device mobility, [F] user-machine interface, [G] advanced features of exoskeleton, [H] end users, [I] patient age group, [J] exoskeleton setting for patients and [K] grant of breakthrough device designation. Additionally, it includes information on [L] exoskeleton technology / software, [M] maximum weight of exoskeleton, [N] maximum weight carrying capacity and [O] exoskeleton dimensions. Further, the chapter presents a list of players engaged in the development / commercialization of medical exoskeletons, along with information on their [P] year of establishment, [Q] company size, [R] location of headquarters, [S] company ownership, [T] additional services offered and [U] most active companies (in terms of number of medical exoskeleton offered).
• Product Competitiveness: A comprehensive competitive analysis of medical exoskeletons, examining factors, such as [A] supplier strength, [B] product competitiveness and [C] end users.
• Company Profiles (Detailed Profiles): In-depth profiles of key players offering medical exoskeletons, focusing on [A] company overviews, [B] financial information (if available), [C] product portfolio, [D] recent developments and [E] an informed future outlook.
• Company Profiles (Tabulated Profiles): Short profiles of key players offering medical exoskeletons, focusing on [A] company overviews and [B] product portfolio.
• Partnerships and Collaborations: An analysis of partnerships established in this sector, since 2017, based on several parameters, such as [A] year of partnership, [B] type of partnership (mergers and acquisitions, product development and commercialization agreements, licensing agreements, service agreements, product development and manufacturing agreements, joint ventures, manufacturing and supply agreements, and product distribution agreements), [C] type of partner (industry and non-industry), [D] business globalization and [E] most active players. This section also highlights the regional distribution of partnership activity in this market.
• Patent Analysis: Detailed analysis of various patents filed / granted based on [A] type of patent, [B] patent application year, [C] patent publication year, [D] geographical location, [E] type of applicant, [F] publication time, [G] top CPC symbols, [H] leading players (in terms of number of patents filed / granted), along with [I] a detailed patent benchmarking analysis.
• Blue Ocean Strategy: A comprehensive analysis of current and future market based on blue ocean strategy, covering a strategic plan / guide for emerging medical exoskeleton companies to help unlock an uncontested market, highlighting thirteen strategic tools that can help to shift towards blue ocean to gain a competitive edge in the market.
• Market Impact Analysis: The report analyzes various factors such as drivers, restraints, opportunities, and challenges affecting market growth.

Key Questions Answered in this Report

• How many companies are currently engaged in this market?
• What factors are likely to influence the evolution of this market?
• What is the current and future market size?
• What is the CAGR of this market?
• How is the current and future market opportunity likely to be distributed across key market segments?

Reasons to Buy this Report

• The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
• Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
• The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

Additional Benefits

• Complimentary PPT Insights Packs
• Complimentary Excel Data Packs for all Analytical Modules in the Report
• 15% Free Content Customization
• Detailed Report Walkthrough Session with Research Team
• Free Updated report if the report is 6-12 months old or older

TABLE OF CONTENTS

1. PREFACE

• 1.1. Introduction
• 1.2. Key Market Insights
• 1.3. Scope of the Report
• 1.4. Research Methodology
• 1.5. Key Questions Answered
• 1.6. Chapter Outlines

2. RESEARCH METHODOLOGY

• 2.1. Chapter Overview
• 2.2. Research Assumptions
• 2.3. Project Methodology
• 2.4. Forecast Methodology
• 2.5. Robust Quality Control
• 2.6. Key Market Segmentations
• 2.7. Key Considerations
  • 2.7.1. Demographics
  • 2.7.2. Economic Factors
  • 2.7.3. Government Regulations
  • 2.7.4. Supply Chain
  • 2.7.5. COVID Impact / Related Factors
  • 2.7.6. Market Access
  • 2.7.7. Healthcare Policies
  • 2.7.8. Industry Consolidation

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS

• 3.1. Chapter Overview
• 3.2. Market Dynamics
  • 3.2.1. Time Period
    • 3.2.1.1. Historical Trends
    • 3.2.1.2. Current and Forecasted Estimates
  • 3.2.2. Currency Coverage
    • 3.2.2.1. Overview of Major Currencies Affecting the Market
    • 3.2.2.2. Impact of Currency Fluctuations on the Industry
  • 3.2.3. Foreign Exchange Impact
    • 3.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
    • 3.2.3.2. Strategies for Mitigating Foreign Exchange Risk
  • 3.2.4. Recession
    • 3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
    • 3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
  • 3.2.5. Inflation
    • 3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
    • 3.2.5.2. Potential Impact of Inflation on the Market Evolution

4. EXECUTIVE SUMMARY

5. INTRODUCTION

• 5.1. Chapter Overview
• 5.2. Overview of Exoskeletons
• 5.3. History of Exoskeletons
• 5.4. Classification of Exoskeletons
  • 5.4.1. Based on Body Part Supported
  • 5.4.2. Based on Form of Exoskeleton
  • 5.4.3. Based on Mode of Operation
  • 5.4.4 Based on Mobility
• 5.5. Features of Exoskeletons
• 5.6. Limitations of Exoskeletons
• 5.7. Applications of Exoskeletons
• 5.8. Future Aspects of Exoskeletons

6. MEDICAL EXOSKELETONS: MARKET LANDSCAPE

• 6.1. Chapter Overview
• 6.2. Medical Exoskeletons: Overall Market Landscape
  • 6.2.1. Analysis by Status of Development
  • 6.2.2. Analysis by Type of Body Part Covered
  • 6.2.3. Analysis by Mode of Operation
  • 6.2.4. Analysis by Type of Body Part Covered and Mode of Operation
  • 6.2.5. Analysis by Form of Exoskeleton
  • 6.2.6. Analysis by Mode of Operation and Form of Exoskeleton
  • 6.2.7. Analysis by Type of Body Part Covered and Form of Exoskeleton
  • 6.2.8. Analysis by Device Mobility
  • 6.2.9. Analysis by Mode of Operation and Device Mobility
  • 6.2.10. Analysis by Form of Exoskeleton and Device Mobility
  • 6.2.11. Analysis by Type of Body Part Covered and Device Mobility
  • 6.2.12. Analysis by User-Machine Interface
  • 6.2.13. Analysis by Type of Body Part Covered and User-Machine Interface
  • 6.2.14. Analysis by Mode of Operation and User-Machine Interface
  • 6.2.15. Analysis by Availability of Advanced Features
  • 6.2.16. Analysis by End User
  • 6.2.17. Analysis by Patient Age Group
  • 6.2.18. Analysis by Exoskeleton Setting for Patients
  • 6.2.19. Analysis by Breakthrough Designation
• 6.3. Medical Exoskeletons: Developer: Landscape
  • 6.3.1. Analysis by Year of Establishment
  • 6.3.2. Analysis by Company Size
  • 6.3.3. Analysis by Location of Headquarters
  • 6.3.4. Analysis by Company Size and Location of Headquarters (Region)
  • 6.3.5. Analysis by Company Ownership
  • 6.3.6. Analysis by Location of Headquarters (Region) and Company Ownership
  • 6.3.7. Analysis by Additional Services Offered
  • 6.3.8. Most Active Players: Analysis by Number of Medical Exoskeletons

7. NON-MEDICAL EXOSKELETONS: MARKET LANDSCAPE

• 7.1. Chapter Overview
• 7.2. Non-Medical Exoskeletons: Overall Market Landscape
  • 7.2.1. Analysis by Status of Development
  • 7.2.2. Analysis by Type of Body Part Covered
  • 7.2.3. Analysis by Body Part Supported
  • 7.2.4. Analysis by Mode of Operation
  • 7.2.5. Analysis by Form of Exoskeleton
  • 7.2.6. Analysis by Type of Body Part Covered and Mode of Operation
  • 7.2.7. Analysis by Type of Body Part Covered and Form of Exoskeleton
  • 7.2.8. Analysis by Mode of Operation and Form of Exoskeleton
  • 7.2.9. Analysis by Application Area
  • 7.2.10. Analysis by Mode of Operation and Application Area
• 7.3. Non-Medical Exoskeletons: Developer Landscape
  • 7.3.1. Analysis by Year of Establishment
  • 7.3.2. Analysis by Company Size
  • 7.3.3. Analysis by Company Size and Employee Count
  • 7.3.4. Analysis by Location of Headquarters
  • 7.3.5. Analysis by Company Size and Location of Headquarters (Region)
  • 7.3.6. Analysis by Company Ownership
  • 7.3.7. Analysis by Location of Headquarters (Region) and Company Ownership
  • 7.3.8. Most Active Players: Analysis by Number of Non-Medical Exoskeletons
  • 7.3.9. Most Active Players: Analysis by Number of Exoskeletons

8. MEDICAL EXOSKELETONS: PRODUCT COMPETITIVENESS ANALYSIS

• 8.1. Chapter Overview
• 8.2. Assumptions and Key Parameters
• 8.3. Methodology
• 8.4. Medical Exoskeletons: Product Competitiveness Analysis
  • 8.4.1. Product Competitiveness Analysis: Upper Body Medical Exoskeletons
    • 8.4.1.1. Product Competitiveness Analysis: Powered Upper Body Exoskeletons
    • 8.4.1.2. Product Competitiveness Analysis: Passive Upper Body Exoskeletons
    • 8.4.1.3. Product Competitiveness Analysis: Hybrid Upper Body Exoskeletons
  • 8.4.2. Product Competitiveness Analysis: Lower Body Exoskeletons
    • 8.4.2.1. Product Competitiveness Analysis: Powered Lower Body Exoskeletons
    • 8.4.2.2. Product Competitiveness Analysis: Passive Lower Body Exoskeletons
    • 8.4.2.3. Product Competitiveness Analysis: Hybrid Lower Body Exoskeletons
  • 8.4.3. Product Competitiveness Analysis: Full Body Medical Exoskeletons

9. EXOSKELETON DEVELOPERS: DETAILED COMPANY PROFILES

• 9.1. Chapter Overview
• 9.2. CYBERDYNE
  • 9.2.1. Company Overview
  • 9.2.2. Financial Information
  • 9.2.3. Product Portfolio
  • 9.2.4 Recent Developments and Future Outlook
• 9.3. Ekso Bionics
  • 9.3.1. Company Overview
  • 9.3.2. Financial Information
  • 9.3.3. Product Portfolio
  • 9.3.4 Recent Developments and Future Outlook
• 9.4. ExoAtlet
  • 9.4.1. Company Overview
  • 9.4.2. Product Portfolio
  • 9.4.3. Recent Developments and Future Outlook
• 9.5. Fourier Intelligence
  • 9.5.1. Company Overview
  • 9.5.2. Product Portfolio
  • 9.5.3. Recent Developments and Future Outlook
• 9.6. Gloreha
  • 9.6.1. Company Overview
  • 9.6.2. Product Portfolio
  • 9.6.3. Recent Developments and Future Outlook
• 9.7. Guangzhou Yikang
  • 9.7.1. Company Overview
  • 9.7.2. Product Portfolio
  • 9.7.3. Recent Developments and Future Outlook
• 9.8. Hexar Humancare
  • 9.8.1. Company Overview
  • 9.8.2. Product Portfolio
  • 9.8.3. Recent Developments and Future Outlook
• 9.9. Hocoma
  • 9.9.1. Company Overview
  • 9.9.2. Product Portfolio
  • 9.9.3. Recent Developments and Future Outlook
• 9.10. Panasonic
  • 9.10.1. Company Overview
  • 9.10.2. Financial Information
  • 9.10.3. Product Portfolio
  • 9.10.4. Recent Developments and Future Outlook
• 9.11. Tyromotion
  • 9.11.1. Company Overview
  • 9.11.2. Product Portfolio
  • 9.11.3. Recent Developments and Future Outlook

10. EXOSKELETON DEVELOPERS: TABULATED COMPANY PROFILES

• 10.1. Chapter Overview
• 10.2. Bionic Yantra
  • 10.2.1. Company Overview
  • 10.2.2. Product Portfolio
• 10.3. MediTouch
  • 10.3.1. Company Overview
  • 10.3.2. Product Portfolio
• 10.4. Milebot Robotics
  • 10.4.1. Company Overview
  • 10.4.2. Product Portfolio
• 10.5. Myomo
  • 10.5.1. Company Overview
  • 10.5.2. Product Portfolio
• 10.6. Neofect
  • 10.6.1. Company Overview
  • 10.6.2. Product Portfolio
• 10.7. NextStep Robotics
  • 10.7.1. Company Overview
  • 10.7.2. Product Portfolio
• 10.8. ReWalk Robotics
  • 10.8.1. Company Overview
  • 10.8.2. Product Portfolio
• 10.9. Rex Bionics
  • 10.9.1. Company Overview
  • 10.9.2. Product Portfolio
• 10.10. Roam Robotics
  • 10.10.1. Company Overview
  • 10.10.2. Product Portfolio
• 10.11. Trexo Robotics
  • 10.11.1. Company Overview
  • 10.11.2. Product Portfolio
• 10.12. U&O Technologies
  • 10.12.1. Company Overview
  • 10.12.2. Product Portfolio

11. MEDICAL EXOSKELETONS: PARTNERSHIPS AND COLLABORATIONS

• 11.1. Chapter Overview
• 11.2. Partnership Models
• 11.3. Medical Exoskeletons: List of Partnerships and Collaborations
  • 11.3.1. Analysis by Year of Partnership
  • 11.3.2. Analysis by Type of Partnership
  • 11.3.3. Analysis by Year and Type of Partnership
  • 11.3.4. Analysis by Purpose of Partnership
  • 11.3.5. Analysis by Type and Purpose of Partnership
  • 11.3.6. Analysis by Type of Partner
  • 11.3.7. Analysis by Year of Partnership and Type of Partner
  • 11.3.8. Analysis by Type of Non-Industry Players
  • 11.3.9. Most Active Players: Distribution by Number of Partnerships
  • 11.3.10. Analysis by Geography
    • 11.3.10.1. Local and International Agreements
    • 11.3.10.2. Intracontinental and Intercontinental Agreements

12. PATENT ANALYSIS

• 12.1. Chapter Overview
• 12.2. Scope and Methodology
• 12.3. Exoskeletons: Patent Analysis
  • 12.3.1. Analysis by Patent Application Year
  • 12.3.2. Analysis by Patent Publication Year
  • 12.3.3. Analysis by Type of Patent and Patent Publication Year
  • 12.3.4. Analysis by Publication Time
  • 12.3.5. Analysis by Patent Jurisdiction
  • 12.3.6. Analysis by CPC symbols
  • 12.3.7. Analysis by Type of Applicant
  • 12.3.8. Leading Industry Players: Analysis by Number of Patents
  • 12.3.9. Leading Non-Industry Players: Analysis by Number of Patents
  • 12.3.10. Leading Patent Assignees: Analysis by Number of Patents
• 12.4. Exoskeletons: Patent Benchmarking
  • 12.4.1. Analysis by Patent Characteristics
  • 12.4.2. Exoskeleton: Patent Valuation
• 12.5. Leading Players by Number of Citations

13. BLUE OCEAN STRATEGY

• 13.1. Overview of Blue Ocean Strategy
  • 13.1.1. Red Oceans
  • 13.1.2. Blue Oceans
  • 13.1.3. Comparison of Red Ocean Strategy and Blue Ocean Strategy
  • 13.1.4. Medical Exoskeletons: Blue Ocean Strategy and Shift Tools
    • 13.1.4.1. Strategy Canvas
    • 13.1.4.2. Pioneer-Migrator-Settler (PMS) Map
    • 13.1.4.3. Buyer Utility Map

14. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES

• 14.1. Chapter Overview
• 14.2. Market Drivers
• 14.3. Market Restraints
• 14.4. Market Opportunities
• 14.5. Market Challenges
• 14.6. Conclusion

15. GLOBAL EXOSKELETONS MARKET

• 15.1. Chapter Overview
• 15.2. Forecast Methodology and Key Assumptions
• 15.3. Global Exoskeletons Market, Historical Trends (since 2018) and Forecasted Estimates (till 2035)
  • 15.3.1. Scenario Analysis
    • 15.3.1.1. Conservative Scenario
    • 15.3.1.2. Optimistic Scenario
• 15.4. Key Market Segmentations

16. EXOSKELETONS MARKET, BY BODY PART COVERED

• 16.1. Chapter Overview
• 16.2. Forecast Methodology and Key Assumptions
• 16.3. Overall Exoskeletons Market: Distribution by Body Part Covered
  • 16.3.1. Overall Upper Body Exoskeletons: Historical Trends (since 2018) and Forecasted Estimates (till 2035)
  • 16.3.2. Overall Lower Body Exoskeletons: Historical Trends (since 2018) and Forecasted Estimates (till 2035)
  • 16.3.3. Overall Full Body Exoskeletons: Historical Trends (since 2018) and Forecasted Estimates (till 2035)
• 16.4. Medical Exoskeletons Market: Distribution by Body Part Covered
  • 16.4.1 Medical Upper Body Exoskeletons: Historical Trends (since 2018) and Forecasted Estimates (till 2035)
  • 16.4.2. Medical Lower Body Exoskeletons: Historical Trends (since 2018) and Forecasted Estimates (till 2035)
  • 16.4.3. Medical Full Body Exoskeletons: Historical Trends (since 2018) and Forecasted Estimates (till 2035)
• 16.5. Non-Medical Exoskeletons Market: Distribution by Body Part Covered
  • 16.5.1. Non-Medical Upper Body Exoskeletons: Historical Trends (since 2018) and Forecasted Estimates (till 2035)
  • 16.5.2. Non-Medical Lower Body Exoskeletons: Historical Trends (since 2018) and Forecasted Estimates (till 2035)
  • 16.5.3. Non-Medical Full Body Exoskeletons: Historical Trends (since 2018) and Forecasted Estimates (till 2035)
• 16.6. Data Triangulation and Validation

17. EXOSKELETONS MARKET, BY MODE OF OPERATION

• 17.1. Chapter Overview
• 17.2. Forecast Methodology and Key Assumptions
• 17.3. Overall Exoskeletons Market: Distribution by Mode of Operation
  • 17.3.1. Overall Powered Exoskeletons Market: Historical Trends (since 2018) and Forecasted Estimates (till 2035)
  • 17.3.2. Overall Passive Exoskeletons Market: Historical Trends (since 2018) and Forecasted Estimates (till 2035)
  • 17.3.3. Overall Hybrid Exoskeletons Market: Historical Trends (since 2018) and Forecasted Estimates (till 2035)
• 17.4. Medical Exoskeletons Market: Distribution by Mode of Operation
  • 17.4.1. Medical Powered Exoskeletons Market: Historical Trends (since 2018) and Forecasted Estimates (till 2035)
  • 17.4.2. Medical Passive Exoskeletons Market: Historical Trends (since 2018) and Forecasted Estimates (till 2035)
  • 17.4.3. Medical Hybrid Exoskeletons Market: Historical Trends (since 2018) and Forecasted Estimates (till 2035)
• 17.5. Non-Medical Exoskeletons Market: Distribution by Mode of Operation
  • 17.5.1. Non-Medical Powered Exoskeletons Market: Historical Trends (since 2018) and Forecasted Estimates (till 2035)
  • 17.5.2. Non-Medical Passive Exoskeletons Market: Historical Trends (since 2018) and Forecasted Estimates (till 2035)
  • 17.5.3. Non-Medical Hybrid Exoskeletons Market: Historical Trends (since 2018) and Forecasted Estimates (till 2035)
• 17.6. Data Triangulation and Validation

18. EXOSKELETON MARKETS, BY THEIR FORM

• 18.1. Chapter Overview
• 18.2. Forecast Methodology and Key Assumptions
• 18.3. Overall Exoskeletons Market: Distribution by Form
  • 18.3.1. Overall Rigid Exoskeletons: Historical Trends (since 2018) and Forecasted Estimates (till 2035)
  • 18.3.2. Overall Soft Exoskeletons: Historical Trends (since 2018) and Forecasted Estimates (till 2035)
• 18.4. Medical Exoskeletons Market: Distribution by Form
  • 18.4.1. Medical Rigid Exoskeletons: Historical Trends (since 2018) and Forecasted Estimates (till 2035)
  • 18.4.2. Medical Soft Exoskeletons: Historical Trends (since 2018) and Forecasted Estimates (till 2035)
• 18.5. Non-Medical Exoskeletons Market: Distribution by Form
  • 18.5.1. Non-Medical Rigid Exoskeletons: Historical Trends (since 2018) and Forecasted Estimates (till 2035)
  • 18.5.2. Non-Medical Soft Exoskeletons: Historical Trends (since 2018) and Forecasted Estimates (till 2035)
• 18.6. Data Triangulation and Validation

19. EXOSKELETON MARKETS, BY THEIR MOBILITY

• 19.1. Chapter Overview
• 19.2. Forecast Methodology and Key Assumptions
• 19.3. Medical Exoskeletons Market: Distribution by Mobility
  • 19.3.1. Medical Fixed/ Supported Exoskeleton: Historical Trends (since 2018) and Forecasted Estimates (till 2035)
  • 19.3.2. Medical Mobile / Overground Walking Exoskeleton: Historical Trends (since 2018) and Forecasted Estimates (till 2035)
• 19.4. Data Triangulation and Validation

20. EXOSKELETONS MARKET, BY END USERS

• 20.1. Chapter Overview
• 20.2. Forecast Methodology and Key Assumptions
• 20.3. Overall Exoskeletons Market: Distribution by End Users
• 20.4. Exoskeletons Market for Patients: Historical Trends (since 2018) and Forecasted Estimates (till 2035)
• 20.5. Exoskeletons Market for Healthcare Providers: Historical Trends (since 2018) and Forecasted Estimates (till 2035)
• 20.6. Exoskeletons Market for Industry Workers: Historical Trends (since 2018) and Forecasted Estimates (till 2035)
• 20.7. Exoskeletons Market for Military Personnel: Historical Trends (since 2018) and Forecasted Estimates (till 2035)
• 20.8. Exoskeletons Market for Other End Users: Historical Trends (since 2018) and Forecasted Estimates (till 2035)
• 20.9. Data Triangulation and Validation

21. EXOSKELETONS MARKET, BY GEOGRAPHY

• 21.1. Chapter Overview
• 21.2. Forecast Methodology and Key Assumptions
• 21.3. Overall Exoskeletons Market: Distribution by Geography
  • 21.3.1. North America, Historical Trends (since 2018) and Forecasted Estimates (till 2035)
  • 21.3.2 Europe, Historical Trends (since 2018) and Forecasted Estimates (till 2035)
  • 21.3.3. Asia-Pacific, Historical Trends (since 2018) and Forecasted Estimates (till 2035)
  • 21.3.4. Rest of the World, Historical Trends (since 2018) and Forecasted Estimates (till 2035)
• 21.4. Data Triangulation and Validation

22. CONCLUSION

23. EXECUTIVE INSIGHTS

• 23.1. Chapter Overview
• 23.2. Company A
  • 23.2.1. Company Snapshot
  • 23.2.2. Interview Transcript: Co-Founder and Chief Executive Officer
• 23.3. Company B
  • 23.3.1. Company Snapshot
  • 23.3.2. Interview Transcript: Director of Business Planning and Development
• 23.4. Company C
  • 23.4.1. Company Snapshot
  • 23.4.2. Interview Transcript: Vice President of Sales and Marketing
• 23.5. Company D
  • 23.5.1. Company Snapshot
  • 23.5.2. Interview Transcript: Founder and Director
• 23.6. Company E
  • 23.6.1. Company Snapshot
  • 23.6.2. Interview Transcript: Marketing and Design Manager

24. APPENDIX I: BLUE OCEAN STRATEGY AND SHIFT TOOLS

• 24.1. Chapter Overview
• 24.2. Blue Ocean Strategy and Shift Tools
  • 24.2.1. Value Innovation
  • 24.2.2. Four Action Framework
  • 24.2.3. Eliminate-Raise-Reduce-Create (ERRC) Grid
  • 24.2.4. Six Path Framework
  • 24.2.5. Three Tiers of Non-customers
• 24.3 Sequence of Blue Ocean Strategy
  • 24.3.1. The Price Corridor of the Mass
  • 24.3.2. Four Hurdles to Strategy Execution
  • 24.3.3. Tipping Point Leadership
  • 24.3.4. Fair Process

25. APPENDIX II: TABULATED DATA

26. APPENDIX III: LIST OF COMPANIES AND ORGANIZATION